Correlation Between BioAffinity Technologies and Guardant Health

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Guardant Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Guardant Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies Warrant and Guardant Health, you can compare the effects of market volatilities on BioAffinity Technologies and Guardant Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Guardant Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Guardant Health.

Diversification Opportunities for BioAffinity Technologies and Guardant Health

-0.69

Correlation Coefficient

BioAffinity Technologies  Guardant Health

Excellent diversification

The 3 months correlation between BioAffinity and Guardant is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Guardant Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guardant Health and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Guardant Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guardant Health has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Guardant Health go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Guardant Health

Assuming the 90 days horizon bioAffinity Technologies Warrant is expected to generate 15.39 times more return on investment than Guardant Health. However, BioAffinity Technologies is 15.39 times more volatile than Guardant Health. It trades about 0.09 of its potential returns per unit of risk. Guardant Health is currently generating about 0.03 per unit of risk. If you would invest  39.00  in bioAffinity Technologies Warrant on October 5, 2024 and sell it today you would lose (5.00) from holding bioAffinity Technologies Warrant or give up 12.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	73.95%
Values	Daily Returns

bioAffinity Technologies Warra  vs.  Guardant Health

BioAffinity Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days bioAffinity Technologies Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Guardant Health

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Guardant Health are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Guardant Health demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioAffinity Technologies and Guardant Health

The main advantage of trading using opposite BioAffinity Technologies and Guardant Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Guardant Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardant Health will offset losses from the drop in Guardant Health's long position.

The idea behind bioAffinity Technologies Warrant and Guardant Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.